In contrast, Isg15 was found to be overexpressed in numerous primary human cancers, including endometrial tumors[11], pancreatic adenocarcinomas[12], tumors of the breast [13, 14], bladder[15], and prostate[16, 17]. Here, ISG15 is linked to pancreatic adenocarcinoma.